SCHEMBL14342573

SCHEMBL14342573

C/C=C/c1cc(C)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL568783 0.80 — —
SCHEMBL28655162 0.76 — —
SCHEMBL15667964 0.74 — —
SCHEMBL10622080 0.73 — —
SCHEMBL20442998 0.71 GSK3B (0.30) —
SCHEMBL14342575 0.70 PTGS2 (0.67) —
SCHEMBL20073808 0.67 NPC1 (0.31) —
SCHEMBL1503 0.66 — —
SCHEMBL15374805 0.66 SMN1; SMN2 (0.37) —
SCHEMBL14342574 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237385-B1 MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER US HEALTH (US) 2021-11-24 — — EP disclosed
WO-2016137506-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. (US) 2016-09-01 — — WO disclosed
US-8710038-B2 Pyrazole kinase modulators and methods of use EXELIXIS, INC. (US) 2014-04-29 — — US disclosed
US-20070293507-A1 Pyrazole Kinase Modulators And Methods Of Use EXELIXIS, INC. (US) 2007-12-20 — — US disclosed
Send feedback